A pharmaceutical composition comprising an Anti-PD-l1 antibody and medical use thereof
TW202641845APending Publication Date: 2026-10-16JIANGSU HENGRUI MEDICINE CO LTD +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115102671
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-12-18
- Filing Date
- 2026-01-22
- Publication Date
- 2026-10-16
Abstract
The disclosure relates to a pharmaceutical composition comprising anti-PD-L1 antibody and medical use thereof. In particular, the disclosure relates to a pharmaceutical composition comprising an anti-PD-L1 antibody and hyaluronidase, and use thereof for the treatment of tumors.
Need to check novelty before this filing date? Find Prior Art